By Emily Flitter and Katya Wachtel NEW YORK (Reuters) – Steven A. Cohen’s hedge fund SAC Capital Advisors told investors on Friday it would no longer cooperate "unconditionally" with the U.S. government’s insider trading investigation. In a brief letter to investors, the $15 billion hedge fund did not elaborate but said it believes the next [...]
By Richard Cowan and Rachelle Younglai WASHINGTON (Reuters) – Prospects for passage of a major immigration bill improved on Thursday when a bipartisan group of lawmakers in the House of Representatives declared they had reached a tentative deal, resolving disputes that had threatened to torpedo negotiations. The breakthrough came at the end of a two-hour [...]
BEIJING (Reuters) – Four more people in China have died from a new strain of bird flu, bringing to 31 the number of deaths from the mysterious H7N9 virus, with the number of infections rising by two to 129, according to Chinese health authorities. Among the deaths, two occurred in the eastern province of Jiangsu; [...]
By David Morgan WASHINGTON (Reuters) – Healthcare reform should be the signature Democratic achievement of President Barack Obama’s presidency. But with "Obamacare" five months from show time, Democrats are worried about whether enough Americans will sign up to make the sweeping healthcare overhaul a success – and what failure might mean for Congress heading into [...]
By Susan Cornwell and Jane Sutton (Reuters) – With his renewed vow to close the detention camp for foreign terrorism suspects at Guantanamo Bay, President Barack Obama has effectively assigned himself a list of possible ways to take the prison’s population down from 166 to zero. Some would be more easily achieved than others. In [...]
By Ransdell Pierson (Reuters) – Merck & Co Inc reported disappointing first-quarter sales on a surprising downturn for its Januvia diabetes medicine, the company’s biggest product and usual earnings driver, and the drugmaker cut its profit forecast for the full year. Shares of Merck fell 3.1 percent in premarket trading. The drugmaker’s earnings beat forecasts [...]
(Reuters) – Pfizer Inc reported lower-than-expected quarterly earnings and revenue, and the largest U.S. drugmaker trimmed its full-year profit outlook, sending its shares down 3 percent. The company said on Tuesday that it earned $2.75 billion, or 38 cents per share, in the first quarter. That compared with $1.79 billion, or 24 cents per share, [...]
By Bill Berkrot NEW YORK (Reuters) – As the clock ticks down to the start of a U.S. healthcare overhaul, companies from device makers to hospital chains have been surprised to see Americans make even fewer trips to the doctor’s office. Use of non-emergency medical services has been weak for several years in the wake [...]
GENEVA (Reuters) – Two more people have died from a new strain of avian influenza, bringing to 20 the number of deaths from the H7N9 virus, the World Health Organization (WHO) said on Sunday. Chinese authorities have notified the WHO of six new cases, bringing the total to 102. Of those, 70 are still in [...]
By Megha Rajagopalan and Kate Kelland BEIJING/LONDON (Reuters) – Health officials raised further questions on Friday about the source of a new strain of bird flu infecting humans in China after data indicated that more than half of patients had had no contact with poultry. The H7N9 virus has been found in 87 people, mostly [...]
